Merck’s Covid Pill Approved in the UK
By Radiant Health EditorsPublished: November 6, 2021
Merck achieved something unprecedented when the United Kingdom announced that it was authorizing the company’s antiviral pill to be used on Covid-19 patients. The drug will be made available to patients who experience Covid-19 symptoms and have at least one risk factor like heart disease, obesity, or are over the age of 60. The UK concurred that the pill is safe and effective and decreases deaths and hospitalizations. The therapeutic, molnupiravir, can be taken at home in the first few days after symptoms appear.
Like what you're reading? Sign up for our free newsletter and never miss a post! Plus get a FREE digital version of our Issue No.10 with sign up.
- Coconut Cauliflower Rice With Jerk Chicken - November 29, 2024
- Protein Cottage Cheese Pancakes - November 27, 2024
- How To Reduce Screen Time On Phone: 5 Helpful Strategies To Help You Stay Connected With The Real World - October 30, 2024
- 11 Wellness Gift Ideas: Perfect Presents for Her that Nurture Body, Mind, and Soul - October 13, 2024
- 11 Best Indoor Air Purifying Plants: Nature’s Air Filters for Your Home - September 27, 2024
- 11 Best Health and Wellness Books to Read in 2025 - July 4, 2024
- Some Americans Will Have Medical Debt Wiped From Credit - July 9, 2022
- Natural Gas Used to Heat Homes Contains Some Harmful Chemicals - July 9, 2022
- Uterine Cancer Claims Many Black Lives - July 9, 2022
- Babies and Toddlers Get COVID-19 Shots - June 27, 2022